Federal regulators plan to take legal action soon against several companies accused of backdating stock options. It's a widening scandal that may affect hundreds of companies. Scott Tong explains.
Host Cheryl Glaser and Newsweek Wall Street editor Allan Sloan look at what's behind the push to partner GM with Nissan and Renault. It may not be what you think.
The nation's largest biotech company in terms of market capitalization blew past Wall Street expectations in its most recent earnings report. Rachel Dornhelm has more.
Second quarter earnings reports are expected to be strong, but don't count on Wall Street to react positively. Bob Moon explains why some investors may not be impressed, even though earnings may be impressive.